Table 1

GVHD is not diminished in congenital acid sphingomyelinase deficiency, Niemann-Pick A/B disease

Graft/diseaseNProbability
Acute GVHD, grades 2-4, at day 100 after HCT (95% CI)Chronic GVHD at 3 y after HCT (95% CI)
MSD BM    
    Niemann-Pick 13 30% (9%-55%) 12% (6%-49%) 
    Other IEM* 202 22% (16%-28%) 9% (6%-14%) 
URD BM + CB    
    Niemann-Pick 11 18% (3%-44%) None 
    Other IEM* 543 39% (34%-43%) 20% (17%-24%) 
Total    
    Niemann-Pick 24 25% (10%-43%) 13% (3%-30%) 
    Other IEM* 745 34% (31%-37%) 16% (13%-19%) 
Graft/diseaseNProbability
Acute GVHD, grades 2-4, at day 100 after HCT (95% CI)Chronic GVHD at 3 y after HCT (95% CI)
MSD BM    
    Niemann-Pick 13 30% (9%-55%) 12% (6%-49%) 
    Other IEM* 202 22% (16%-28%) 9% (6%-14%) 
URD BM + CB    
    Niemann-Pick 11 18% (3%-44%) None 
    Other IEM* 543 39% (34%-43%) 20% (17%-24%) 
Total    
    Niemann-Pick 24 25% (10%-43%) 13% (3%-30%) 
    Other IEM* 745 34% (31%-37%) 16% (13%-19%) 

N indicates number of cases; CI, confidence interval; BM, bone marrow; CB, cord blood; IEM, inborn errors of metabolism; MSD, matched sibling donor; and URD, unrelated donor.

Unrelated donor-recipient matching at human leukocyte antigens (HLAs) for BM recipients included 2 cases of 6/6 antigen-matched and 1 case of 5/6 antigen-matched. After typing at the HLA-C locus became available, 1 transplantation was performed that was 6/8 antigen-matched (mismatch at the HLA-B locus, and allele mismatch at the HLA-C locus). For CB transplants, 1 was 6/6, 5 were 5/6, and 1 was 4/6 antigen-matched.

*

Similarly aged patients with IEM from the CIBMTR database who underwent transplantation between 1987 and 2007.

No patient developed chronic GVHD.

or Create an Account

Close Modal
Close Modal